Pattern of Mas expression in acute and post-acute stage of nerve injury in mice
•Mas receptor is differentially expressed in acute and post-acute phase after axotomy.•Antagonist of the Mas receptor (A779) causes worse result in sciatic functional test.•A779 affects the Schwann cell activity and the number of macrophages after axotomy. Angiotensin-(1–7) (Ang [1–7]) and its recep...
Gespeichert in:
Veröffentlicht in: | Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2017-10, Vol.96, p.15-19 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 19 |
---|---|
container_issue | |
container_start_page | 15 |
container_title | Peptides (New York, N.Y. : 1980) |
container_volume | 96 |
creator | Assis, Alex Dias de Assis Araújo, Fernanda dos Santos, Robson Augusto Souza Andrade, Silvia Passos Zanon, Renata Graciele |
description | •Mas receptor is differentially expressed in acute and post-acute phase after axotomy.•Antagonist of the Mas receptor (A779) causes worse result in sciatic functional test.•A779 affects the Schwann cell activity and the number of macrophages after axotomy.
Angiotensin-(1–7) (Ang [1–7]) and its receptor Mas are involved in a number of physiological processes, including control of arterial pressure and modulation of nervous system actions. However, the involvement of the Ang-(1–7)/Mas axis in peripheral nerve injury has not been investigated. Using a model of sciatic nerve injury in mice, we demonstrated opposing changes in Mas receptor expression at days 2 and 14 post-injury. Mas receptor expression was more intense 2days after the nerve lesion, compared with the intensity of the intact nerve. At this time point, the sciatic nerve functional index was −20. At day 14 after the lesion, the intensity of the immunostaining labeling in longitudinal sections of the nerve was reduced (∼30%) and the functional index increased +36 (gait improvement). In the axotomized group treated with A779 (a Mas receptor antagonist), the functional recovery index decreased in relation to the untreated axotomized group. The Mas receptor inhibitor also altered the intensity of labeling of S-100, GAP43, and IBA-1 (morphological features compatible with delayed axon growth). This study demonstrated that Ang-(1–7)/Mas axis activity was differentially modulated in the acute and post-acute stages of nerve injury. |
doi_str_mv | 10.1016/j.peptides.2017.08.008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1935811441</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0196978117302693</els_id><sourcerecordid>1935811441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-d46a6ce1dabf283b1cf2bd1f053aa8c37d5a2eeea26920b0da7f34edee8342863</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EoqXwC1WWbBL8SBxnB6p4SUVlAWvLsSfIUZsE26no35MoLVtWo5HOnas5CC0JTggm_K5OOuiCNeATikmeYJFgLM7QnIicxRnhxTmaY1LwuMgFmaEr72uMcZoW4hLNqBA5zgsxR5t3FQK4Jmqr6E35CH46B97btolsEyndB4hUY6Ku9SGeVh_UF4x8A24PA1b37jDSO6vhGl1Uauvh5jgX6PPp8WP1Eq83z6-rh3WsGRchNilXXAMxqqyoYCXRFS0NqXDGlBKa5SZTFAAU5QXFJTYqr1gKBkCwlArOFuh2utu59rsHH-TOeg3brWqg7b0kBcsEIWlKBpRPqHat9w4q2Tm7U-4gCZajTFnLk0w5ypRYyEHmEFweO_pyB-YvdrI3APcTAMOnewtOem2h0WCsAx2kae1_Hb8nnYph</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1935811441</pqid></control><display><type>article</type><title>Pattern of Mas expression in acute and post-acute stage of nerve injury in mice</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Assis, Alex Dias ; de Assis Araújo, Fernanda ; dos Santos, Robson Augusto Souza ; Andrade, Silvia Passos ; Zanon, Renata Graciele</creator><creatorcontrib>Assis, Alex Dias ; de Assis Araújo, Fernanda ; dos Santos, Robson Augusto Souza ; Andrade, Silvia Passos ; Zanon, Renata Graciele</creatorcontrib><description>•Mas receptor is differentially expressed in acute and post-acute phase after axotomy.•Antagonist of the Mas receptor (A779) causes worse result in sciatic functional test.•A779 affects the Schwann cell activity and the number of macrophages after axotomy.
Angiotensin-(1–7) (Ang [1–7]) and its receptor Mas are involved in a number of physiological processes, including control of arterial pressure and modulation of nervous system actions. However, the involvement of the Ang-(1–7)/Mas axis in peripheral nerve injury has not been investigated. Using a model of sciatic nerve injury in mice, we demonstrated opposing changes in Mas receptor expression at days 2 and 14 post-injury. Mas receptor expression was more intense 2days after the nerve lesion, compared with the intensity of the intact nerve. At this time point, the sciatic nerve functional index was −20. At day 14 after the lesion, the intensity of the immunostaining labeling in longitudinal sections of the nerve was reduced (∼30%) and the functional index increased +36 (gait improvement). In the axotomized group treated with A779 (a Mas receptor antagonist), the functional recovery index decreased in relation to the untreated axotomized group. The Mas receptor inhibitor also altered the intensity of labeling of S-100, GAP43, and IBA-1 (morphological features compatible with delayed axon growth). This study demonstrated that Ang-(1–7)/Mas axis activity was differentially modulated in the acute and post-acute stages of nerve injury.</description><identifier>ISSN: 0196-9781</identifier><identifier>EISSN: 1873-5169</identifier><identifier>DOI: 10.1016/j.peptides.2017.08.008</identifier><identifier>PMID: 28870798</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Angiotensin II - analogs & derivatives ; Angiotensin II - pharmacology ; Animals ; Axon repair ; Axotomy ; GAP-43 Protein - metabolism ; Male ; Mas receptor ; Mice ; Peptide Fragments - pharmacology ; Peripheral nerve ; Peripheral Nerves - drug effects ; Peripheral Nerves - metabolism ; Peripheral Nerves - pathology ; Proto-Oncogene Proteins - antagonists & inhibitors ; Proto-Oncogene Proteins - metabolism ; Receptors, G-Protein-Coupled - antagonists & inhibitors ; Receptors, G-Protein-Coupled - metabolism ; S100 Proteins - metabolism ; Sciatic Neuropathy - metabolism</subject><ispartof>Peptides (New York, N.Y. : 1980), 2017-10, Vol.96, p.15-19</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-d46a6ce1dabf283b1cf2bd1f053aa8c37d5a2eeea26920b0da7f34edee8342863</citedby><cites>FETCH-LOGICAL-c368t-d46a6ce1dabf283b1cf2bd1f053aa8c37d5a2eeea26920b0da7f34edee8342863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.peptides.2017.08.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28870798$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Assis, Alex Dias</creatorcontrib><creatorcontrib>de Assis Araújo, Fernanda</creatorcontrib><creatorcontrib>dos Santos, Robson Augusto Souza</creatorcontrib><creatorcontrib>Andrade, Silvia Passos</creatorcontrib><creatorcontrib>Zanon, Renata Graciele</creatorcontrib><title>Pattern of Mas expression in acute and post-acute stage of nerve injury in mice</title><title>Peptides (New York, N.Y. : 1980)</title><addtitle>Peptides</addtitle><description>•Mas receptor is differentially expressed in acute and post-acute phase after axotomy.•Antagonist of the Mas receptor (A779) causes worse result in sciatic functional test.•A779 affects the Schwann cell activity and the number of macrophages after axotomy.
Angiotensin-(1–7) (Ang [1–7]) and its receptor Mas are involved in a number of physiological processes, including control of arterial pressure and modulation of nervous system actions. However, the involvement of the Ang-(1–7)/Mas axis in peripheral nerve injury has not been investigated. Using a model of sciatic nerve injury in mice, we demonstrated opposing changes in Mas receptor expression at days 2 and 14 post-injury. Mas receptor expression was more intense 2days after the nerve lesion, compared with the intensity of the intact nerve. At this time point, the sciatic nerve functional index was −20. At day 14 after the lesion, the intensity of the immunostaining labeling in longitudinal sections of the nerve was reduced (∼30%) and the functional index increased +36 (gait improvement). In the axotomized group treated with A779 (a Mas receptor antagonist), the functional recovery index decreased in relation to the untreated axotomized group. The Mas receptor inhibitor also altered the intensity of labeling of S-100, GAP43, and IBA-1 (morphological features compatible with delayed axon growth). This study demonstrated that Ang-(1–7)/Mas axis activity was differentially modulated in the acute and post-acute stages of nerve injury.</description><subject>Angiotensin II - analogs & derivatives</subject><subject>Angiotensin II - pharmacology</subject><subject>Animals</subject><subject>Axon repair</subject><subject>Axotomy</subject><subject>GAP-43 Protein - metabolism</subject><subject>Male</subject><subject>Mas receptor</subject><subject>Mice</subject><subject>Peptide Fragments - pharmacology</subject><subject>Peripheral nerve</subject><subject>Peripheral Nerves - drug effects</subject><subject>Peripheral Nerves - metabolism</subject><subject>Peripheral Nerves - pathology</subject><subject>Proto-Oncogene Proteins - antagonists & inhibitors</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Receptors, G-Protein-Coupled - antagonists & inhibitors</subject><subject>Receptors, G-Protein-Coupled - metabolism</subject><subject>S100 Proteins - metabolism</subject><subject>Sciatic Neuropathy - metabolism</subject><issn>0196-9781</issn><issn>1873-5169</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EoqXwC1WWbBL8SBxnB6p4SUVlAWvLsSfIUZsE26no35MoLVtWo5HOnas5CC0JTggm_K5OOuiCNeATikmeYJFgLM7QnIicxRnhxTmaY1LwuMgFmaEr72uMcZoW4hLNqBA5zgsxR5t3FQK4Jmqr6E35CH46B97btolsEyndB4hUY6Ku9SGeVh_UF4x8A24PA1b37jDSO6vhGl1Uauvh5jgX6PPp8WP1Eq83z6-rh3WsGRchNilXXAMxqqyoYCXRFS0NqXDGlBKa5SZTFAAU5QXFJTYqr1gKBkCwlArOFuh2utu59rsHH-TOeg3brWqg7b0kBcsEIWlKBpRPqHat9w4q2Tm7U-4gCZajTFnLk0w5ypRYyEHmEFweO_pyB-YvdrI3APcTAMOnewtOem2h0WCsAx2kae1_Hb8nnYph</recordid><startdate>201710</startdate><enddate>201710</enddate><creator>Assis, Alex Dias</creator><creator>de Assis Araújo, Fernanda</creator><creator>dos Santos, Robson Augusto Souza</creator><creator>Andrade, Silvia Passos</creator><creator>Zanon, Renata Graciele</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201710</creationdate><title>Pattern of Mas expression in acute and post-acute stage of nerve injury in mice</title><author>Assis, Alex Dias ; de Assis Araújo, Fernanda ; dos Santos, Robson Augusto Souza ; Andrade, Silvia Passos ; Zanon, Renata Graciele</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-d46a6ce1dabf283b1cf2bd1f053aa8c37d5a2eeea26920b0da7f34edee8342863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Angiotensin II - analogs & derivatives</topic><topic>Angiotensin II - pharmacology</topic><topic>Animals</topic><topic>Axon repair</topic><topic>Axotomy</topic><topic>GAP-43 Protein - metabolism</topic><topic>Male</topic><topic>Mas receptor</topic><topic>Mice</topic><topic>Peptide Fragments - pharmacology</topic><topic>Peripheral nerve</topic><topic>Peripheral Nerves - drug effects</topic><topic>Peripheral Nerves - metabolism</topic><topic>Peripheral Nerves - pathology</topic><topic>Proto-Oncogene Proteins - antagonists & inhibitors</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Receptors, G-Protein-Coupled - antagonists & inhibitors</topic><topic>Receptors, G-Protein-Coupled - metabolism</topic><topic>S100 Proteins - metabolism</topic><topic>Sciatic Neuropathy - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Assis, Alex Dias</creatorcontrib><creatorcontrib>de Assis Araújo, Fernanda</creatorcontrib><creatorcontrib>dos Santos, Robson Augusto Souza</creatorcontrib><creatorcontrib>Andrade, Silvia Passos</creatorcontrib><creatorcontrib>Zanon, Renata Graciele</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Peptides (New York, N.Y. : 1980)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Assis, Alex Dias</au><au>de Assis Araújo, Fernanda</au><au>dos Santos, Robson Augusto Souza</au><au>Andrade, Silvia Passos</au><au>Zanon, Renata Graciele</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pattern of Mas expression in acute and post-acute stage of nerve injury in mice</atitle><jtitle>Peptides (New York, N.Y. : 1980)</jtitle><addtitle>Peptides</addtitle><date>2017-10</date><risdate>2017</risdate><volume>96</volume><spage>15</spage><epage>19</epage><pages>15-19</pages><issn>0196-9781</issn><eissn>1873-5169</eissn><abstract>•Mas receptor is differentially expressed in acute and post-acute phase after axotomy.•Antagonist of the Mas receptor (A779) causes worse result in sciatic functional test.•A779 affects the Schwann cell activity and the number of macrophages after axotomy.
Angiotensin-(1–7) (Ang [1–7]) and its receptor Mas are involved in a number of physiological processes, including control of arterial pressure and modulation of nervous system actions. However, the involvement of the Ang-(1–7)/Mas axis in peripheral nerve injury has not been investigated. Using a model of sciatic nerve injury in mice, we demonstrated opposing changes in Mas receptor expression at days 2 and 14 post-injury. Mas receptor expression was more intense 2days after the nerve lesion, compared with the intensity of the intact nerve. At this time point, the sciatic nerve functional index was −20. At day 14 after the lesion, the intensity of the immunostaining labeling in longitudinal sections of the nerve was reduced (∼30%) and the functional index increased +36 (gait improvement). In the axotomized group treated with A779 (a Mas receptor antagonist), the functional recovery index decreased in relation to the untreated axotomized group. The Mas receptor inhibitor also altered the intensity of labeling of S-100, GAP43, and IBA-1 (morphological features compatible with delayed axon growth). This study demonstrated that Ang-(1–7)/Mas axis activity was differentially modulated in the acute and post-acute stages of nerve injury.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28870798</pmid><doi>10.1016/j.peptides.2017.08.008</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0196-9781 |
ispartof | Peptides (New York, N.Y. : 1980), 2017-10, Vol.96, p.15-19 |
issn | 0196-9781 1873-5169 |
language | eng |
recordid | cdi_proquest_miscellaneous_1935811441 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Angiotensin II - analogs & derivatives Angiotensin II - pharmacology Animals Axon repair Axotomy GAP-43 Protein - metabolism Male Mas receptor Mice Peptide Fragments - pharmacology Peripheral nerve Peripheral Nerves - drug effects Peripheral Nerves - metabolism Peripheral Nerves - pathology Proto-Oncogene Proteins - antagonists & inhibitors Proto-Oncogene Proteins - metabolism Receptors, G-Protein-Coupled - antagonists & inhibitors Receptors, G-Protein-Coupled - metabolism S100 Proteins - metabolism Sciatic Neuropathy - metabolism |
title | Pattern of Mas expression in acute and post-acute stage of nerve injury in mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A59%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pattern%20of%20Mas%20expression%20in%20acute%20and%20post-acute%20stage%20of%20nerve%20injury%20in%20mice&rft.jtitle=Peptides%20(New%20York,%20N.Y.%20:%201980)&rft.au=Assis,%20Alex%20Dias&rft.date=2017-10&rft.volume=96&rft.spage=15&rft.epage=19&rft.pages=15-19&rft.issn=0196-9781&rft.eissn=1873-5169&rft_id=info:doi/10.1016/j.peptides.2017.08.008&rft_dat=%3Cproquest_cross%3E1935811441%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1935811441&rft_id=info:pmid/28870798&rft_els_id=S0196978117302693&rfr_iscdi=true |